Business Wire4d
Celltrion's Infliximab, the First Monoclonal Antibody Biosimilar, Is Now Remdantry ™ in Canada
indications and dosages of Remdantry will remain the same as that of Inflectra, which was originally approved by the Health Canada for the treatment of rheumatoid arthritis (RA), plaque psoriasis ...
WKRN-TV14d
Head-to-Head Preclinical Studies of SFA-002 as a Novel Psoriasis Treatment Presented at the 2025 American Academy of Dermatology Annual Meeting
"Psoriasis can be a challenging condition to manage due to long-term treatments with various side effects. SFA-002's effect in the imiquimod-induced mouse model is compelling. The results ...
Montreal News10d
Celltrion’s Infliximab, the First Monoclonal Antibody Biosimilar, Is Now Remdantry™ in Canada
indications and dosages of Remdantry will remain the same as that of Inflectra, which was originally approved by the Health Canada for the treatment of rheumatoid arthritis (RA), plaque psoriasis ...